|
The investigation determined that higher and lower than expected phenobarbital (phbr) results were obtained from two levels of non-vitros biorad qc fluid and from one level of vitros therapeutic drug monitoring (tdm) performance verifier (pv) fluids using vitros chemistry products phbr slides lot 2504-0091-0846 on a vitros xt7600 integrated system.The assignable cause for the higher and lower than expected results of 16.43 and 15.68 that were obtained prior to the calibration on 05 apr 2023 is unknown.The calibration that was in use at the time that these results is not available for review, therefore it is unknown if the calibration for these results was a contributor to the event.The assignable cause for the remaining lower and higher than expected results of 7.07, 10.11, 10.26, 10.32 and 98.99 is a suboptimal calibration, although the cause of the suboptimal calibration is unknown.A new calibration was performed with parameters that were more typical to expectation, and acceptable results were obtained at that time with no changes in reagent or actions to the analyzer.An issue with immunowash fluid (iwf) fluid handling cannot be confirmed or ruled out as a contributor to the events.The customer did not provide their protocol for iwf handling when requested.There is no indication that the vitros xt7600 integrated system or the vitros phbr reagent malfunctioned in any way.Vitros tdm performance verifier results were within expectation following the most recent calibration performed with new calibrator fluids, a new vitros phbr cartridge and new iwf fluid with no other actions performed to the analyzer.Continual tracking and trending of complaints has not identified any signals that would indicate a potential systematic issue with vitros phbr reagent lot 2504-0091-0846.
|
|
A customer contacted the ortho clinical diagnostics (ortho) technical solution center (tsc) to report higher and lower than expected phenobarbital (phbr) results were obtained from two levels of non-vitros biorad qc fluid and from one level of vitros therapeutic drug monitoring (tdm) performance verifier (pv) fluids using vitros chemistry products phbr slides lot 2504-0091-0846 on a vitros xt7600 integrated system.Tdm pvi lot k9187 vitros phbr results of 10.11, 10.26 and 10.32 ug/ml; versus the expected result of 13.56 ug/ml biorad level 1 lot 85311 vitros phbr results of 7.07, 16.43 and 15.68 ug/ ml; versus the expected result of 10.3 ug/ml biorad level 3 lot 85313 vitros phbr result of 98.99 ug/ ml versus the expected result of 73.3 ug/ml.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The higher and lower than expected vitros phbr results were obtained from a quality control fluid and no results were reported from the laboratory.Ortho has not been made aware of any allegation of patient harm as a result of this event.This report is number two of three mdr¿s for this event.Three 3500a forms are being submitted for this event as three devices were involved.This report corresponds to ortho clinical diagnostics inc (ortho) complaint number (b)(4) and reportability assessment 601758.
|